Cloning of aklavinone biosynthesis genes from Streptomyces galilaeus.
Aklavinone is an aglycone of aclacinomycin A which is an important antitumor drug. Genes for the biosynthesis of aklavinone were cloned from Streptomyces galilaeus 3AR-33, an aklavinone-producing mutant, by use of the actI and actIII polyketide synthase gene probes. Restriction mapping and Southern analysis of the DNA cloned in a lambda phage vector established that the DNA represented three different regions of the S. galilaeus 3AR-33 genome that contained 3.4, 2.5, and 4.1 kb BamHI fragments which hybridized with actIII. Of those, only the 3.4 kb fragment also hybridized with actI. Complementation experiments with specifically blocked mutants confirmed that the cloned 3.4 kb BamHI fragment contains the genes required for the early stage of polyketide synthesis in aklavinone biosynthesis.
Tsukamoto
N
N
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
Fujii
I
I
Ebizuka
Y
Y
Sankawa
U
U
D000903:Antibiotics, Antineoplastic / Q000096:biosynthesis*; D003001:Cloning, Molecular; D015723:Gene Library; D005798:Genes, Bacterial; D005816:Genetic Complementation Test; D009097:Multienzyme Complexes / Q000235:genetics*; D009154:Mutation; D009279:Naphthacenes / Q000378:metabolism; D013302:Streptomyces / Q000235:genetics*
D000903:Antibiotics, Antineoplastic; D009097:Multienzyme Complexes; D009279:Naphthacenes; C027832:aklavinone